Clinical Microbiomics A/S Acquires DNASense, Expanding Frontiers in Microbiome Science Across Diverse Ecosystems

Clinical Microbiomics A/S^1, the global microbiome science company,  announces the acquisition of DNASense ApS, an innovative Danish microbiome C...

March 04, 2024 | Monday | News
NeuroBo Gets Initial IRB Approval for Obesity Treatment Trial DA-1726

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases,  announced that...

March 01, 2024 | Friday | News
BeiGene Reports BRUKINSA® Outperforms Acalabrutinib in Chronic Leukemia Study

BeiGene, Ltd. announced a new matching adjusted indirect comparison (MAIC) of the efficacy of BRUKINSA® (zanubrutinib) versus acalabrutinib in relapsed...

March 01, 2024 | Friday | News
Trinity Life Sciences Launches Brand Insights AI

“GenAI is poised to revolutionize how insights leaders harness the collective power of all their research investments to make quick, informed decisio...

February 29, 2024 | Thursday | News
QIAGEN Introduces AI-Powered Biomedical Database to Boost Drug Discovery

QIAGEN announced the launch of QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base designed to propel drug discovery in the pharma and biote...

February 28, 2024 | Wednesday | News
Ember LifeSciences Partners with USADA to Revolutionize Blood Sample Shipping for 2024 U.S. Olympic Trials

  At the heart of this innovative partnership is the Ember Cube, a symbol of cutting-edge advancement in the cold chain sector. This technology is se...

February 28, 2024 | Wednesday | News
Bristol Myers Squibb Acquires RayzeBio, Expands with Actinium Radiopharmaceuticals

Bristol Myers Squibb (NYSE: BMY) announced that it has successfully completed its acquisition of RayzeBio, Inc. (NASDAQ: RYZB). With the completion of the ...

February 27, 2024 | Tuesday | News
Bitterroot Bio and Biotheus Launch Joint Effort to Create Bispecific Proteins for Cardio-Immunology

Bitterroot Bio, a leader in innovative treatments for cardiovascular diseases, and Biotheus, a pioneer in monoclonal and multi-specific antibody design, an...

February 27, 2024 | Tuesday | News
Korea University Study Explores a Novel and Precise Mitochondrial Gene Editing Method

          Targeted base editing of mammalian mtDNA is a powerful technology f...

February 26, 2024 | Monday | News
Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Elevating Single Cell Sequencing Solutions

Parse Biosciences, a pioneering provider of accessible and scalable single cell sequencing solutions, has announced a significant update to its flagship Ev...

February 22, 2024 | Thursday | News
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology

  In a bold move, Vaccinex has forged eight new antibody discovery agreements with leading pharmaceutical and biotechnology companies, as well as str...

February 21, 2024 | Wednesday | News
Almirall S.A. Partners with Novo Nordisk to Develop Novel Dermatological Therapy

  "This new partnership builds on our innovation strategy and will allow us to explore the innovative approach of IL-21 blockage as a possible new pa...

February 20, 2024 | Tuesday | News
Bio-Rad's CEO, Norman Schwartz, Anticipates Sector Rebound in 2024 Amid Fourth Quarter Challenges

Bio-Rad Laboratories Inc. reports a 6.7% decrease in fourth-quarter net sales compared to 2022, largely attributed to ongoing weakness in biopharma markets...

February 16, 2024 | Friday | Company results
Eppendorf Group opens site in South Africa

Johannesburg is now the hub for all Southern African countries. In addition to SouthAfrica; Botswana, Namibia, Mozambique, Zambia, Zimbabwe, Lesotho, Ang...

February 16, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close